A syringe with the needle point to the vaccine vial on the colorful abstract background
SurVaxM Phase I Completed
Phase I clinical trial results of SurVaxM presented at AACR Annual Meeting 2015 in Philadelphia BUFFALO, N.Y. — A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in…